Also trades as: 0460.HK (HKSE) · $vol 3M
SHPHF OTC
Sihuan Pharmaceutical Holdings Group Ltd.
1W: +0.0%
1M: +0.0%
3M: -7.5%
YTD: -25.0%
1Y: +21.7%
3Y: +58.7%
5Y: -41.4%
$0.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.1B
52W Range0.0492-0.2103
Volume0
Avg Volume33
Beta0.89
Dividend$0.00
Analyst Ratings
No analyst coverage
Company Info
CEOWei Cheng Guo
Employees2,843
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2012-01-13
Websitesihuanpharm.com
Office Tower, Convention Plaza
Hong Kong 590-8522
HK
Hong Kong 590-8522
HK
852 3628 3911
About Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
Recent Insider Trades
No insider trades found